Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16431 | 653 | 32.2 | 57% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
16431 | 1 | LY 300164//FLUNARIZINE//EXPTL EPILEPSIEFOR | 653 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LY 300164 | authKW | 299263 | 1% | 80% | 8 |
2 | FLUNARIZINE | authKW | 108561 | 4% | 10% | 24 |
3 | EXPTL EPILEPSIEFOR | address | 105209 | 0% | 75% | 3 |
4 | AMINOPHYLLINE INDUCED CONVULSIONS | authKW | 93521 | 0% | 100% | 2 |
5 | FOCAL INTERICTAL EPILEPTIFORM ACTIVITY | authKW | 93521 | 0% | 100% | 2 |
6 | ORGANIC CALCIUM ANTAGONISTS | authKW | 93521 | 0% | 100% | 2 |
7 | THEOPHYLLINE ASSOCIATED SEIZURES | authKW | 93521 | 0% | 100% | 2 |
8 | ELECTROSHOCK MAXIMAL | authKW | 63635 | 1% | 19% | 7 |
9 | CR 2039 | authKW | 62346 | 0% | 67% | 2 |
10 | MODEL NERVOUS SYSTEM | authKW | 62346 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3922 | 45% | 0% | 297 |
2 | Neurosciences | 2363 | 36% | 0% | 234 |
3 | Clinical Neurology | 1230 | 20% | 0% | 130 |
4 | Psychiatry | 181 | 7% | 0% | 46 |
5 | Physiology | 71 | 5% | 0% | 30 |
6 | Chemistry, Medicinal | 44 | 3% | 0% | 21 |
7 | Behavioral Sciences | 43 | 2% | 0% | 15 |
8 | Toxicology | 23 | 3% | 0% | 17 |
9 | Zoology | 17 | 3% | 0% | 17 |
10 | Medicine, Research & Experimental | 8 | 3% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPTL EPILEPSIEFOR | 105209 | 0% | 75% | 3 |
2 | DIPART INGN BIOFIS ELETTRON | 46760 | 0% | 100% | 1 |
3 | EXPTL EPILEPSIEFOR HUFFERSTR 68 | 46760 | 0% | 100% | 1 |
4 | PHARMACOL FMRP | 46760 | 0% | 100% | 1 |
5 | PHARMACOL R D | 46760 | 0% | 100% | 1 |
6 | PHARMACOL TOXICOL JACZEWSKIEGO 8 | 46760 | 0% | 100% | 1 |
7 | PSYCHOBIOL FFCLRP | 46760 | 0% | 100% | 1 |
8 | S FISIOL FARMACOL CONDUCTUAL BIOQUIM BIOINFO | 46760 | 0% | 100% | 1 |
9 | SECC CIENCIAS BIOL SALUD HUMANA | 46760 | 0% | 100% | 1 |
10 | EXPT EPILEPSIEFOR | 37398 | 1% | 13% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | POLISH JOURNAL OF PHARMACOLOGY | 25578 | 3% | 3% | 19 |
2 | EPILEPSIA | 8790 | 6% | 0% | 41 |
3 | NEUROPHARMACOLOGY | 4168 | 4% | 0% | 29 |
4 | EUROPEAN JOURNAL OF PHARMACOLOGY | 3034 | 7% | 0% | 43 |
5 | NEUROSCIENCE RESEARCH COMMUNICATIONS | 2989 | 1% | 1% | 7 |
6 | POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY | 2939 | 1% | 1% | 7 |
7 | EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2482 | 2% | 0% | 11 |
8 | METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2154 | 2% | 0% | 11 |
9 | PHARMACOLOGICAL REPORTS | 2099 | 1% | 1% | 9 |
10 | BRAIN RESEARCH | 1950 | 7% | 0% | 45 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STRAUB, H , KOHLING, R , SPECKMANN, EJ , (1996) ANTIEPILEPTIC CALCIUM ANTAGONISM IN HUMAN AND ANIMAL NEOCORTICAL TISSUE.EEG-EMG-ZEITSCHRIFT FUR ELEKTROENZEPHALOGRAPHIE ELEKTROMYOGRAPHIE UND VERWANDTE GEBIETE. VOL. 27. ISSUE 4. P. 226-235 | 31 | 86% | 1 |
2 | KULAK, W , SOBANIEC, W , WOJTAL, K , CZUCZWAR, SJ , (2004) CALCIUM MODULATION IN EPILEPSY.POLISH JOURNAL OF PHARMACOLOGY. VOL. 56. ISSUE 1. P. 29-41 | 27 | 60% | 35 |
3 | SWIADER, M , BOROWICZ, KK , POREBIAK, J , KLEINROK, Z , CZUCZWAR, SJ , (2002) INFLUENCE OF AGENTS AFFECTING VOLTAGE-DEPENDENT CALCIUM CHANNELS AND DANTROLENE ON THE ANTICONVULSANT ACTION OF THE AMPA/KAINATE RECEPTOR ANTAGONIST LY 300164 IN MICE.EUROPEAN NEUROPSYCHOPHARMACOLOGY. VOL. 12. ISSUE 4. P. 311-319 | 28 | 64% | 6 |
4 | AMBROSIO, AF , SOARES-DA-SILVA, P , CARVALHO, CM , CARVALHO, AP , (2002) MECHANISMS OF ACTION OF CARBAMAZEPINE AND ITS DERIVATIVES, OXCARBAZEPINE, BIA 2-093, AND BIA 2-024.NEUROCHEMICAL RESEARCH. VOL. 27. ISSUE 1-2. P. 121 -130 | 36 | 42% | 115 |
5 | STRAUB, H , KOHLING, R , SPECKMANN, EJ , (1997) STRYCHNINE-INDUCED EPILEPTIFORM ACTIVITY IN HIPPOCAMPAL AND NEOCORTICAL SLICE PREPARATIONS: SUPPRESSION BY THE ORGANIC CALCIUM ANTAGONISTS VERAPAMIL AND FLUNARIZINE.BRAIN RESEARCH. VOL. 773. ISSUE 1-2. P. 173-180 | 23 | 88% | 9 |
6 | STRAUB, H , HOHLING, JM , KOHLING, R , LUCKE, A , TUXHORN, I , EBNER, A , WOLF, P , PANNEK, H , OPPEL, F , SPECKMANN, EJ , (2000) EFFECTS OF NIFEDIPINE ON RHYTHMIC SYNCHRONOUS ACTIVITY OF HUMAN NEOCORTICAL SLICES.NEUROSCIENCE. VOL. 100. ISSUE 3. P. 445-452 | 26 | 68% | 16 |
7 | GASIOR, M , SWIADER, M , PRZYBYLKO, M , BOROWICZ, K , TURSKI, WA , KLEINROK, Z , CZUCZWAR, SJ , (1998) FELBAMATE DEMONSTRATES LOW PROPENSITY FOR INTERACTION WITH METHYLXANTHINES AND CA2+ CHANNEL MODULATORS AGAINST EXPERIMENTAL SEIZURES IN MICE.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 352. ISSUE 2-3. P. 207-214 | 23 | 82% | 5 |
8 | CHROSCINSKA-KRAWCZYK, M , RADZIK, I , MIZIAK, B , CZUCZWAR, SJ , (2014) SAFETY CONSIDERATIONS FOR PATIENTS WITH EPILEPSY TAKING ANTIEPILEPTIC DRUGS ALONGSIDE CAFFEINE OR OTHER METHYLXANTHINE DERIVATIVES.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 10. ISSUE 7. P. 981 -989 | 25 | 45% | 2 |
9 | FISCHER, W , KITTNER, H , REGENTHAL, R , DE SARRO, G , (2004) ANTICONVULSANT PROFILE OF FLUNARIZINE AND RELATION TO NA+ CHANNEL BLOCKING EFFECTS.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 94. ISSUE 2. P. 79-88 | 27 | 48% | 10 |
10 | HASAN, M , PULMAN, J , MARSON, AG , (2013) CALCIUM ANTAGONISTS AS AN ADD-ON THERAPY FOR DRUG-RESISTANT EPILEPSY.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 14 | 74% | 2 |
Classes with closest relation at Level 1 |